0001104659-22-032917.txt : 20220311
0001104659-22-032917.hdr.sgml : 20220311
20220311163301
ACCESSION NUMBER: 0001104659-22-032917
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220309
FILED AS OF DATE: 20220311
DATE AS OF CHANGE: 20220311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KANDERS WARREN B
CENTRAL INDEX KEY: 0000935577
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40698
FILM NUMBER: 22733598
MAIL ADDRESS:
STREET 1: ONE LANDMARK SQUARE
STREET 2: 22ND FLOOR
CITY: STAMFORD,
STATE: CT
ZIP: 06901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cadre Holdings, Inc.
CENTRAL INDEX KEY: 0001860543
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 383873146
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 13386 INTERNATIONAL PKWY
CITY: JACKSONVILLE
STATE: FL
ZIP: 32218
BUSINESS PHONE: (904) 741-5400
MAIL ADDRESS:
STREET 1: 13386 INTERNATIONAL PKWY
CITY: JACKSONVILLE
STATE: FL
ZIP: 32218
4
1
tm228848-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-03-09
0
0001860543
Cadre Holdings, Inc.
CDRE
0000935577
KANDERS WARREN B
C/O CADRE HOLDINGS, INC.
13386 INTERNATIONAL PKWY
JACKSONVILLE
FL
32218
1
1
1
0
CEO AND CHAIRMAN
Common Stock, par value $0.0001 per share ("Common Stock")
2022-03-09
4
A
0
31250
0
A
Common Stock
31250
31250
D
Stock Option (right to purchase)
23.45
2022-03-09
4
A
0
113636
0
A
2032-03-09
Common Stock
113636
113636
D
Comprised of a restricted stock award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 31,250 restricted shares of Common Stock. 10,416 restricted shares of Common Stock will vest and become non-forfeitable on March 9, 2023 and 10,417 restricted shares of Common Stock will vest and become non-forfeitable on each of March 9, 2024 and March 9, 2025.
The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 37,878 shares of the Issuer's Common Stock will vest and become exercisable on March 9, 2023 and options to purchase 37,879 shares of the Issuer's Common Stock will vest and become exercisable on each of March 9, 2024 and March 9, 2025.
/s/ Warren B. Kanders
2022-03-11